Lesaka (LSAK) Q1 2027 Earnings Call Transcript

Lesaka Technologies reported Q1 FY2027 net revenue up 8% year over year to ZAR 1.58 billion, while Adjusted EBITDA fell 17% to ZAR 220 million and Adjusted EPS fell 26% to ZAR 0.72, above its ZAR 0.40–ZAR 0.60 guidance range. Consumer revenue rose 24% and enterprise revenue 19%, but merchant EBITDA declined 51% to ZAR 77 million amid margin pressure and restructuring costs; net operating cash outflow was ZAR 113 million and net debt rose to ZAR 2.73 billion. Management reaffirmed FY2027 revenue guidance of ZAR 7.0–ZAR 7.7 billion and Adjusted EBITDA guidance of ZAR 1.45–ZAR 1.60 billion, while expecting Q2 leverage to rise temporarily to around 3x and the merchant business to recover.

Analysis

The key issue is whether earnings growth converts into self-funded growth. Longer-dated consumer loans and rapid originations can support customer economics, but also tie up cash for longer and amplify credit losses if affordability or collections weaken. A deposit-funded model could reduce reliance on external borrowing, but Bank Zero is not an automatic margin win: regulatory timing, deposit gathering costs, liquidity management and the pace of migrating loans will determine the benefit. Until migration is demonstrated in cash interest expense and leverage, treat the funding upside as optionality rather than base-case value.

Near term, the Q2 earnings step-up is partly seasonal and partly dependent on management’s merchant recovery plan; it is not yet proof of sustainable operating leverage. Community volume growth may require incentives that delay monetization, while corporate recovery is a longer-dated execution risk. Over 1–3 months, focus on Q2 cash conversion, consumer loan arrears/vintages, merchant EBITDA and actual Bank Zero approval progress. Over 6–18 months, the structural test is whether deposits lower funding costs without loosening underwriting, and whether merchant cross-sell improves revenue per merchant rather than merely adding low-yield volume.

Contrarian read: the more consequential downside is not a one-quarter merchant miss but simultaneous funding pressure and credit normalization as the loan book expands. Conversely, if cash conversion improves while credit performance holds, investors may be underweighting the value of a lower-cost funding base. No valuation or liquidity data are supplied, so the earnings call alone does not establish an attractive entry price.

Key Decisions for Investors

• Avoid chasing the Q2 rebound narrative; consider a staged LSAK long only after the next report verifies merchant EBITDA above management’s stated threshold and improving cash conversion. The thesis is falsified by a miss on either, or materially weaker full-year guidance.
• Keep exposure sized for a temporary leverage rise and monitor quarterly net debt, interest expense, loan-book growth and consumer/merchant arrears. A simultaneous increase in arrears and leverage would invalidate the self-funded-growth thesis and warrant reducing exposure.
• Treat Bank Zero as a catalyst, not a completed funding benefit: verify regulatory completion, deposit growth and actual loan migration before underwriting lower funding costs. A further approval delay or no measurable funding-cost improvement after migration is a negative catalyst.
• Before initiating a position, verify current valuation, trading liquidity and borrow availability; the supplied information is insufficient to justify a price target or an outright short.